Trinity Biotech Announces 1-for-30 Reverse ADS Split
Trinity Biotech plc (Nasdaq: TRIB) has announced plans to significantly change the ratio of its American depositary shares (ADSs), effectively implementing a 1-for-30 reverse ADS split for existing holders. The change is expected to take effect at the opening of trading on the Nasdaq Global Market on July 24, 2026. Under the new structure, one…
